SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.00+0.2%12:52 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (20501)5/11/1998 9:04:00 PM
From: squetch  Read Replies (1) of 32384
 
Henry, >>The remainder of the $37 million payment will be used to settle claims of Seragen's creditors and preferred shareholders.<<SRGN has a 5million obligation to who I forgot for advanced future sales. Is this part of that 37?

Now they sold their manufacturing and clinical operations to Boston University back in 2/97. I read it as they have a lease obligation to BU. So that is probably part of the 37.

SRGN has the right to repurchase those assets from BU. I wonder if this is part of the 37? Where are those people gonna work otherwise.

Also in the its not all there file, those who said you aren't I beat you to it(:>), US Surgical still appears to have rights to restenosis after angio. squetch
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News